Esther Amador-Del Valle
Internal Medicine · Miami Beach, FLNPI 1043475684
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 205 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AbbVie at 33.1% of the total. Among internal medicine clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 205 payments — averaging $30.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novo Nordisk$1K
- Johnson & Johnson$618
- Pfizer$383
- Amarin Pharma, Inc.$292
- Viiv Healthcare Company$228
- plus $2K from 20 others
What the payments were for
- Food & beverage$6,336100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 87 | $2,099 |
| Novo Nordisk | 30 | $1,116 |
| Johnson & Johnson | 15 | $618 |
| Pfizer | 10 | $383 |
| Amarin Pharma, Inc. | 10 | $292 |
| Viiv Healthcare Company | 6 | $228 |
| Lilly USA, LLC | 14 | $225 |
| Saluda Medical Americas, Inc. | 2 | $153 |
| Actelion Pharmaceuticals US, Inc. | 1 | $148 |
| Gilead | 2 | $143 |
| Medtronic | 1 | $123 |
| Melinta Therapeutics, LLC | 1 | $121 |
| Inari Medical, Inc. | 1 | $120 |
| Idorsia Pharmaceuticals US Inc | 5 | $110 |
| E.r. Squibb & Sons, L.L.C. | 5 | $101 |
| Bayer | 3 | $84 |
| Eisai Inc. | 2 | $39 |
| Redhill Biopharma Inc. | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 1 | $33 |
| Portola Pharmaceuticals, LLC | 1 | $30 |
| AstraZeneca | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| IBSA Pharma Inc. | 1 | $20 |
| Merck | 1 | $20 |
| Amgen | 1 | $18 |
| Insmed, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wegovy$487
- XARELTO$340
- ELIQUIS$244
- UPTRAVI$148
- OPSUMIT$148
- AVYCAZ$128
- Veklury$127
- APRETUDE$125
- Vascepa$125
- KYPHON Balloon Kyphoplasty$123
- Baxdela$121
- FlowTriever$120
- ClotTriever$120
- Ozempic$120
- Evoke$107
How this compares
$6,336 in reported general payments places this provider in the 90th percentile of 8,530 internal medicine providers in Florida.
Other internal medicine in Miami Beach
- Jason ShapiroMiami Beach$69K
- Haytham ElgammalMiami$2.2M
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
- Quang NguyenOcala$434K
- Luis Correa LunaSanford$412K
- Michael OleksykFort Myers$365K
- Andrew KuykendallTampa$322K
- Howard FederoffCoconut Grove$302K
- Bianka EperjesiovaGainesville$260K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.